Acrodermatitis chronica atrophicans and serologic confirmation of infection due to Borrelia afzelii and/or Borrelia garinii by immunoblot

Clinical Microbiology and Infection

Volumn 4, Issue 3, 1998, Pages 159-163

  Dunand, Viviane A ^a   Bretz, Anne Gabrielle ^b   Suard, André ^c   Praz, Gérard ^b   Dayer, Eric ^b   Péter, Olivier ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Institut Central des Hopitaux Valaisans   (Switzerland)

^c Dermatologue   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORRELIA AFZELII; BORRELIA GARINII; CLINICAL ARTICLE; DERMATITIS; HUMAN; IMMUNOBLOTTING; LYME DISEASE; PRIORITY JOURNAL; SERODIAGNOSIS;

BORRELIA; BORRELIA AFZELII; BORRELIA GARINII;

EID: 0031914756     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00381.x     Document Type: Article

References (15)

1. Steere AC. Lyme disease. N Engl J Med 1989; 321: 586-96.
2. Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 1993; 25: 441-8.
3. Baranton G, Postic D, Saint-Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borreha garinii sp. nov. and group VS 461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42: 378-83.
4. Dressier F, Ackermann R., Steere AC. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis 1994; 169: 313-18.
5. Anthonissen FM, De Kesel M, Hoet PP, Bigaignon GH. Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium. Res Microbiol 1994; 145: 327-31.
6. Assous MV, Postic D, Paul G, Névot P, Baranton G. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis 1993; 12: 261-8.
7. Péter O, Bretz AG, Postic D, Dayer E. Association of distinct species of Borrelia burgdorferi sensu lato with, neuroborreliosis in Switzerland. Clin Microbiol Infect 1997; 3: 423-31.
8. Péter O, Bretz AG. Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification Zentralbl Bakteriol 1992; 277: 28-33.
9. Postic D, Assous M, Grimont PAD, Baranton G. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf(5S)-m(23S) intergenic spacer amplicons. Int J Syst Bacteriol 1994; 44. 743-52.
10. Demaerschalk I, Ben Messaoud A, De Kesel M, et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 1995; 33: 602-8.
11. Rijpkema SGT, Tazelaar DJ, Molkenboer MJCH, et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS 116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin Microbiol infect 1997; 3: 109-16.
12. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans skin lesions. J Clin Microbiol 1992; 30: 3082-8.
13. Nocton JJ, Dressier F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-34.
14. Wilske B, Fingerle V, Preac-Mursic V, et al. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med Microbiol Immunol 1994; 183: 43-59.
15. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995; 146: 329-40.